SH3RF1 and cancer: Furthermore, high-throughput screening revealed that RING finger containing E3 ligase SIAH2 and the signaling platform molecule SH3 domain containing RING finger 1 (SH3RF1) confer robust caspase-8 activation and suggest targeting the interaction of these two E3 ligases is a promising novel cancer therapeutic strategy [218].